irinotecan has been researched along with betadex in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, J; Li, C; Li, Y; Wang, C; Wang, P; Wei, N; Xiu, X; Zhang, L | 1 |
Fongsuk, C; Manaspon, C; Nasongkla, N; Nittayacharn, P; Vejjasilpa, K | 1 |
Carcaboso, AM; Glisoni, R; Lavarino, C; Monterrubio, C; Mora, J; Paco, S; Rodríguez, E; Schaiquevich, P; Sosnik, A; Vila-Ubach, M | 1 |
Fu, J; Guo, M; Liu, D; Liu, H; Sun, B; Wei, W; Yang, W; Yang, Z | 1 |
4 other study(ies) available for irinotecan and betadex
Article | Year |
---|---|
Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
Topics: Ammonium Sulfate; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Capsules; Female; Half-Life; Irinotecan; Lipids; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Polyethylene Glycols; Prostatic Neoplasms; Technology, Pharmaceutical | 2011 |
SN-38:β-cyclodextrin inclusion complex for in situ solidifying injectable polymer implants.
Topics: Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Drug Implants; Irinotecan; Polymers | 2011 |
Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Heterografts; Humans; Hydrophobic and Hydrophilic Interactions; Irinotecan; Mice; Mice, Nude; Microdialysis; Neuroblastoma | 2015 |
The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate.
Topics: Ammonium Sulfate; Animals; Antineoplastic Agents; beta-Cyclodextrins; Colonic Neoplasms; Delayed-Action Preparations; Drug Liberation; HT29 Cells; Humans; Irinotecan; Liposomes; Male; Mice, Nude; Rats, Sprague-Dawley; Sucrose; Topoisomerase I Inhibitors | 2018 |